Literature DB >> 25287722

Fascioliasis: a worldwide parasitic disease of importance in travel medicine.

Keyhan Ashrafi1, M Dolores Bargues2, Sandra O'Neill3, Santiago Mas-Coma4.   

Abstract

Fascioliasis is a foodborne zoonotic disease caused by the two parasite species Fasciola hepatica and Fasciola gigantica. This trematodiasis has never been claimed special relevance for travellers and migrants. However, the situation has drastically changed in the last two decades, in a way that fascioliasis should today be included in the list of diseases to be enhanced in Travel Medicine. Different kind of travellers have been involved in human infection reports: business travellers, tourists, migrants, expatriated workers, military personnel, religious missionaries, and refugees. Europe is the continent where more imported cases have been reported in many countries. More cases would have been probably reported in Europe if fascioliasis would be a reportable disease. In the Americas, most of the reports concern cases diagnosed in USA. Relative few patients have been diagnosed in studies on travellers performed in Asia. In Africa, most cases were reported in Maghreb countries. Blood eosinophilia and the ingestion of watercress or any other suggestive freshwater plant in anamnesis are extremely useful in guiding towards a fascioliasis diagnosis in a developed country, although may not be so in human endemic areas of developing countries. Several suggestive clinical presentation aspects may be useful, although the clinical polymorphism may be misleading in many cases. Non-invasive techniques are helpful for the diagnosis, although images may lead to confusion. Laparoscopic visualization should assist and facilitate procurement of an accurately guided biopsy. Endoscopic retrograde cholangiopancreatography (ERCP) is the first choice in patients in the chronic phase. ERCP and sphincterotomy are used to extract parasites from the biliary tree. Fluke egg finding continues to be the gold standard and enables for burden quantification and establishing of the drug dose. Many serological and stool antigen detection tests have been developed. Immunological techniques present the advantages of being applicable during all periods of the disease, but fundamentally during the invasive or acute period, as well as to other situations in which coprological techniques may present problems. Triclabendazole is the drug of choice at present, although the spread of resistance to this drug is challenging. Prevention mainly concerns measures to avoid individual infection by considering the different human infection sources.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fasciola gigantica; Fasciola hepatica; Increasing traveller reports; Preventive measures; Treatment

Mesh:

Substances:

Year:  2014        PMID: 25287722     DOI: 10.1016/j.tmaid.2014.09.006

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  35 in total

1.  Delineating distinct heme-scavenging and -binding functions of domains in MF6p/helminth defense molecule (HDM) proteins from parasitic flatworms.

Authors:  Victoria Martínez-Sernández; Mercedes Mezo; Marta González-Warleta; María J Perteguer; Teresa Gárate; Fernanda Romarís; Florencio M Ubeira
Journal:  J Biol Chem       Date:  2017-03-27       Impact factor: 5.157

2.  Case Report: First Molecular Diagnosis of Liver Abscesses Due to Fasciola hepatica Acute Infection Imported from Vietnam.

Authors:  Coralie L'Ollivier; Carole Eldin; Emilie Lambourg; Philippe Brouqui; Jean Christophe Lagier
Journal:  Am J Trop Med Hyg       Date:  2020-01       Impact factor: 2.345

3.  Mass Drug Administration of Triclabendazole for Fasciola Hepatica in Bolivia.

Authors:  Sergio Mollinedo; Patricia Gutierrez; Rosa Azurduy; Freddy Valle; Alejandra Salas; Zoraida Mollinedo; Paula Soto; Cleye F Villarroel; Janet Ransom; Robb Lawrence; Jonathan Berman; Jaime Soto
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

4.  Human Fascioliasis (Liver Fluke Disease) in Hawai'i: Case Report and Review of Human Fascioliasis Acquired in the United States.

Authors:  Joel D Brown
Journal:  Hawaii J Health Soc Welf       Date:  2021-09

5.  Gross and histologic description of trematodosis in fetal and neonatal beef calves in North Dakota and Minnesota.

Authors:  Heidi L Pecoraro; Brianna L S Stenger; Laura E Rice; Brett T Webb
Journal:  J Vet Diagn Invest       Date:  2022-06-30       Impact factor: 1.569

Review 6.  Climate Change and the Neglected Tropical Diseases.

Authors:  Mark Booth
Journal:  Adv Parasitol       Date:  2018-03-28       Impact factor: 3.870

7.  Development of Two FhSAP2 Recombinant-Based Assays for Immunodiagnosis of Human Chronic Fascioliasis.

Authors:  Sun Hee Shin; Angel Hsu; Holly M Chastain; Lorna A Cruz; Eric S Elder; Sarah G H Sapp; Isabel McAuliffe; Ana M Espino; Sukwan Handali
Journal:  Am J Trop Med Hyg       Date:  2016-08-22       Impact factor: 2.345

8.  Socioeconomic Factors Associated with Fasciola hepatica Infection Among Children from 26 Communities of the Cusco Region of Peru.

Authors:  Miguel M Cabada; Maria Luisa Morales; Camille M Webb; Logan Yang; Chelsey A Bravenec; Martha Lopez; Ruben Bascope; A Clinton White; Eduardo Gotuzzo
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

9.  Fasciola hepatica in a country of low incidence: a tricky diagnosis.

Authors:  Stéphanie Perrodin; Laura Walti; Bruno Gottstein; Corina Kim-Fuchs; Daniel Candinas; Vanessa Banz
Journal:  Hepatobiliary Surg Nutr       Date:  2019-12       Impact factor: 7.293

Review 10.  Fascioliasis: An Ongoing Zoonotic Trematode Infection.

Authors:  Mramba Nyindo; Abdul-Hamid Lukambagire
Journal:  Biomed Res Int       Date:  2015-08-31       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.